CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform on Monday, June 17th. As previously communicated, the Grifols assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Panther Testing Platform. The new package insert, assay history list, and platform history list are now available on our website.
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
On June 13, 2019, the new CTS Laboratory Information System was successfully implemented in Cha...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...